267 related articles for article (PubMed ID: 1569876)
1. MRI susceptometry: image-based measurement of absolute susceptibility of MR contrast agents and human blood.
Weisskoff RM; Kiihne S
Magn Reson Med; 1992 Apr; 24(2):375-83. PubMed ID: 1569876
[TBL] [Abstract][Full Text] [Related]
2. The magnetic properties of some materials affecting MR images.
Josephson L; Bigler J; White D
Magn Reson Med; 1991 Dec; 22(2):204-8; discussion 213-5. PubMed ID: 1812347
[TBL] [Abstract][Full Text] [Related]
3. Basic physics of MR contrast agents and maximization of image contrast.
Hendrick RE; Haacke EM
J Magn Reson Imaging; 1993; 3(1):137-48. PubMed ID: 8428081
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
5. Iron-dextran as a magnetic susceptibility contrast agent: flow-related contrast effects in the T2-weighted spin-echo MRI of normal rat and cat brain.
White DL; Aicher KP; Tzika AA; Kucharczyk J; Engelstad BL; Moseley ME
Magn Reson Med; 1992 Mar; 24(1):14-28. PubMed ID: 1313524
[TBL] [Abstract][Full Text] [Related]
6. Focal nodular hyperplasia of the liver: serial MRI with Gd-DOTA, superparamagnetic iron oxide, and Gd-EOB-DTPA.
Kacl GM; Hagspiel KD; Marincek B
Abdom Imaging; 1997; 22(3):264-7. PubMed ID: 9107647
[TBL] [Abstract][Full Text] [Related]
7. Basic principles of MR contrast.
Nelson KL; Runge VM
Top Magn Reson Imaging; 1995; 7(3):124-36. PubMed ID: 7654392
[TBL] [Abstract][Full Text] [Related]
8. Application of a superparamagnetic iron oxide (Resovist) for MR imaging of human cerebral blood volume.
Reimer P; Schuierer G; Balzer T; Peters PE
Magn Reson Med; 1995 Nov; 34(5):694-7. PubMed ID: 8544689
[TBL] [Abstract][Full Text] [Related]
9. Combination of gadolinium and dysprosium chelates as a cellular integrity marker in MR imaging.
Ericsson A; Bach-Gansmo T; Niklasson F; Hemmingsson A
Acta Radiol; 1995 Jan; 36(1):41-6. PubMed ID: 7833167
[TBL] [Abstract][Full Text] [Related]
10. Comparison of iron oxide particles (AMI 227) with a gadolinium complex (Gd-DOTA) in dynamic susceptibility contrast MR imagings (FLASH and EPI) for both phantom and rat brain at 1.5 Tesla.
Loubeyre P; De Jaegere T; Bosmans H; Miao Y; Ni Y; Landuyt W; Marchal G
J Magn Reson Imaging; 1999 Mar; 9(3):447-53. PubMed ID: 10194716
[TBL] [Abstract][Full Text] [Related]
11. Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions.
Vogl TJ; Hammerstingl R; Schwarz W; Mack MG; Müller PK; Pegios W; Keck H; Eibl-Eibesfeldt A; Hoelzl J; Woessmer B; Bergman C; Felix R
Radiology; 1996 Mar; 198(3):881-7. PubMed ID: 8628887
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dysprosium DTPA BMA and superparamagnetic iron oxide particles as susceptibility contrast agents for perfusion imaging of regional cerebral ischemia in the rat.
Haraldseth O; Jones RA; Müller TB; Fahlvik AK; Oksendal AN
J Magn Reson Imaging; 1996; 6(5):714-7. PubMed ID: 8890008
[TBL] [Abstract][Full Text] [Related]
13. Role of spatial distribution in proton relaxation enhancement by particulate iron oxide.
Tanimoto A; Yuasa Y; Stark DD
Invest Radiol; 1994 Jun; 29 Suppl 2():S78-80. PubMed ID: 7523329
[No Abstract] [Full Text] [Related]
14. Proton relaxation enhancement.
Wood ML; Hardy PA
J Magn Reson Imaging; 1993; 3(1):149-56. PubMed ID: 8428082
[TBL] [Abstract][Full Text] [Related]
15. High resolution MRI of MCF7 human breast tumors: complemented use of iron oxide microspheres and Gd-DTPA.
Furman-Haran E; Margalit R; Grobgeld D; Degani H
J Magn Reson Imaging; 1998; 8(3):634-41. PubMed ID: 9626879
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of the contrast behavior of typical focal hepatic lesions before and after the administration of Gd-DTPA and superparamagnetic iron oxide particles.
Helmberger T; Holzknecht N; Reiser M
Acad Radiol; 2002 Aug; 9 Suppl 2():S468-72. PubMed ID: 12188311
[No Abstract] [Full Text] [Related]
17. MRI of arthritis: comparison of ultrasmall superparamagnetic iron oxide vs. Gd-DTPA.
Simon GH; von Vopelius-Feldt J; Wendland MF; Fu Y; Piontek G; Schlegel J; Chen MH; Daldrup-Link HE
J Magn Reson Imaging; 2006 May; 23(5):720-7. PubMed ID: 16557494
[TBL] [Abstract][Full Text] [Related]
18. Thioguanin-induced nodular regenerative hyperplasia of the liver-ROC analysis of different MR techniques.
Zech CJ; Seiderer J; Reinisch W; Ochsenkuhn T; Schima W; Diebold J; Wrba F; Reiser MF; Schoenberg SO
Eur Radiol; 2007 Jul; 17(7):1898-905. PubMed ID: 17221208
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
[TBL] [Abstract][Full Text] [Related]
20. Hepatic in vivo video microscopic study for evaluating experimental and approved magnetic resonance contrast agents.
Kruskal JB; Lunderquist A; Clouse ME
Invest Radiol; 1994 Jun; 29 Suppl 2():S83-6. PubMed ID: 7928279
[No Abstract] [Full Text] [Related]
[Next] [New Search]
